Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube

Gastroenterology CE Activities

Gastroenterology blog

View Details

6 Ways to Help You Choose the Right Initial Therapy for Your Patient with Ulcerative Colitis

Choosing the correct first therapy for your patients with ulcerative colitis (UC) can be tricky, but it is important because it gives them the best chance at a better life with UC. Getting it right early increases their odds of remission and reduces their risk of progression, hospitalization, and colectomy. Here are 6 ways to help get it right the first time.
  • Gastroenterology
  • Blog
DOWNLOAD
View Details

These 3 Tools Will Change the Way You Manage IBD in Your Patients

Over the past couple of years, several clinical decision support tools (CDSTs) have emerged to more effectively risk stratify patients and one actually predicts their response to certain biologics before they even start them.
  • Gastroenterology
  • Blog
DOWNLOAD

RMEI Presentations

When the Patient Voice is Heard in Education, Does the Clinican Listen? Dual Track Patient/Provider Education in IBD Incorporating Patients as Learners and Faculty

View Details

The Gastroenterology Learner Pathway in IBD: An Outcomes-Based Iterative Approach to IBD Education Using Advanced Analytics and Predictive Modeling to Sustain Behavioral Change

View Details

LATEST Gastroentrology ARTICLES

RSS Latest Gastroentrology Articles
  • Overweight and Obesity — Capturing the Whole Picture June 12, 2025
    Overweight and obesity represent addressable proximal drivers of chronic disease.1 The prevalence of overweight and obesity is increasing around the world; by 2050, projections indicate that more than half the adult population worldwide will be living with overweight and obesity, most prominently in China (an estimated 627 million...
    Vanita R. Aroda, Leigh Perreault
  • Nutrition in Medicine: Malnutrition in Older Adults June 12, 2025
    Malnutrition in older adults is common, underrecognized, and contributes to poor health and risk of death. Guidelines are available to facilitate prevention and treatment of malnutrition.
    Alfonso J. Cruz-Jentoft, Dorothee Volkert
  • Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight June 12, 2025
    Once-weekly mazdutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, provided clinically relevant reduction in body weight in Chinese adults with obesity or overweight.
    Linong Ji, Hongwei Jiang, Yan Bi, Hua Li, Junhang Tian, Dexue Liu, Yuzhu Zhao, Wei Qiu, Chongbing Huang, Lei Chen, Shao Zhong, Jie Han, Yawei Zhang, Qiufang Lian, Ping Yang, Lingchun Lv, Jieyu Gu, Zihan Liu, Huan Deng, Yanqi Wang, Li Li, Lijuan Pei, Lei Qian, the GLORY-1 Investigators*

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
  • Allergy & Immunology
  • 2021
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.
  • Gastroenterology
  • 2021

Previously Published CE Activities

Copyright © 2025. RMEI Medical Education, LLC. All rights reserved​